Increase of Hemoglobin Levels by Anti-IL-6 Receptor Antibody (Tocilizumab) in Rheumatoid Arthritis

• Motomu Hashimoto ,

  * E-mail: mohashim@kuhp.kyoto-u.ac.jp

  Affiliation Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Takao Fujii,

  Affiliations Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan, Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Masahide Hamaguchi,

  Affiliation Department of Experimental Immunology, Immunology Frontier Research Center, Osaka University, Osaka, Japan

  ⨯
• Moritoshi Furu,

  Affiliation Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Hiromu Ito,

  Affiliations Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan, Department of Orthopedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Chikashi Terao,

  Affiliation Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Keiichi Yamamoto,

  Affiliation Division of Clinical and Epidemiological Database, Department of Information Governance, National Cerebral and Cardiovascular Center, Osaka, Japan

  ⨯
• Wataru Yamamoto,

  Affiliations Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan, Department of Health Information Management, Kurashiki Sweet Hospital, Kurashiki, Japan

  ⨯
• Takashi Matsuo,

  Affiliation Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Masato Mori,

  Affiliation Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Koichiro Ohmura,

  Affiliation Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Hiroshi Kawabata,

  Affiliation Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Tsuneyo Mimori

  Affiliation Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯